The physician-patient relationship and quality of life: Lessons from chronic lymphocytic leukemia

Leukemia Research

Volumn 33, Issue 2, 2009, Pages 263-270

  Shanafelt, Tait D ^a   Bowen, Deborah A ^a   Venkat, Chaya ^b   Slager, Susan L ^a   Zent, Clive S ^a   Kay, Neil E ^a   Reinalda, Megan ^a   Tun, Han ^a   Sloan, Jeff A ^a   Call, Timothy G ^a  

^a Mayo Clinic College of Medicine   (United States)

^b CLL Topics   (United States)

Author keywords

Chronic lymphocytic leukemia; Communication; Leukemia; Quality of life; Supportive care

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; COMORBIDITY; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FATIGUE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; PATIENT ATTITUDE; PATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE;

ANXIETY; DATA COLLECTION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE;

EID: 56949085137     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.06.019     Document Type: Article

References (37)

1. Morton L.M., Wang S.S., Devesa S.S., et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107 (2006) 265-276
2. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
3. Zent C.S., Kyasa M.J., Evans R., et al. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 92 (2001) 1325-1330
4. Call T., Phyilky R., Noel P., et al. Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clinic Proc 69 (1994) 323-328
5. Rozman C., Bosch F., and Montserrat E. Chronic lymphocytic leukemia: a changing natural history?. Leukemia 11 (1997) 775-778
6. Molica S., and Levato D. What is changing in the natural history of chronic lymphocytic leukaemia. Haematologica 86 (2001) 8-12
7. Dighiero G., Maloum K., Desablens B., et al. Chlorambucil in indolent chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 338 (1998) 1506-1514
8. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group. J Natl Cancer Inst 91 (1999) 861-868
9. Molica S. Quality of life in chronic lymphocytic leukemia: a neglected issue. Leuk Lymphoma 46 (2005) 1709-1714
10. Levy V., Porcher R., Delabarre F., et al. Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis. J Clin Epidemiol 54 (2001) 747-754
11. Eichhorst B.F., Busch R., Obwandner T., et al. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group. J Clin Oncol (2007)
12. Rossi J.F., van Hoof A., de Boeck K., et al. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukaemia. J Clin Oncol 22 (2004) 1260-1267
13. Else M., Smith A.G., Hawkins K., et al. Quality of life in the LRF CLL4 trial. Blood 106 (2005) 2111 [Abstract#]
14. Fallowfield L., and Jenkins V. Communicating sad, bad, and difficult news in medicine. Lancet 363 (2004) 312-319
15. Back A.L., Arnold R.M., Baile W.F., et al. Approaching difficult communication tasks in oncology. CA Cancer J Clin 55 (2005) 164-177
16. Baile W.F., and Beale E.A. Giving bad news to cancer patients: matching process and content. J Clin Oncol 21 (2003) 49s-51s
17. Jenkins V., Fallowfield L., and Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84 (2001) 48-51
18. Baile W.F., Lenzi R., Parker P.A., et al. Oncologists' attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol 20 (2002) 2189-2196
19. Back A.L., Arnold R.M., Baile W.F., et al. Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 167 (2007) 453-460
20. Shanafelt T.D., Bowen D., Venkat C., et al. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol 139 (2007) 255-264
21. Brucker P.S., Yost K., Cashy J., et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28 (2005) 192-211
22. Holzner B., Kemmler G., Cella D., et al. Normative data for functional assessment of cancer therapy-general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol 43 (2004) 153-160
23. Cella D., Zagari M.J., Vandoros C., et al. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 21 (2003) 366-373
24. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
25. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
26. Holzner B., Bode R.K., Hahn E.A., et al. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer 42 (2006) 3169-3177
27. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85 (1999) 1186-1196
28. Rai K. A Critical Analysis of Staging in CLL (1987), Alan R Liss, New York
29. Sloan J.A., Frost M.H., Berzon R., et al. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer 14 (2006) 988-998
30. Sloan J.A. Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions. COPD 2 (2005) 57-62
31. Sloan J.A. Applying QOL assessments: solutions for oncology clinical practice and research. Part 1. Curr Probl Cancer 29 (2005) 271-351
32. Pollak K.I., Arnold R.M., Jeffreys A.S., et al. Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol 25 (2007) 5748-5752
33. Derogatis L.R., Morrow G.R., Fetting J., et al. The prevalence of psychiatric disorders among cancer patients. JAMA 249 (1983) 751-757
34. Davies R., Davis B., and Sibert J. Parents' stories of sensitive and insensitive care by paediatricians in the time leading up to and including diagnostic disclosure of a life-limiting condition in their child. Child Care Health Dev 29 (2003) 77-82
35. Fallowfield L., Jenkins V., Farewell V., et al. Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 359 (2002) 650-656
36. Jenkins V., and Fallowfield L. Can communication skills training alter physicians' beliefs and behavior in clinics?. J Clin Oncol 20 (2002) 765-769
37. Fallowfield L., Jenkins V., Farewell V., et al. Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer 89 (2003) 1445-1449